17 February 2012 19:09 [Source: ICIS news]
LONDON (ICIS)--The CEO of Germany-based chemicals firm LANXESS is ruling out suggestions that his firm should merge with specialty chemicals producer Evonik, he said on Friday.
A leading politician in LANXESS' home state of North Rhine-Westphalia recently suggested that RAG-Stiftung, a government-controlled coal foundation which holds the majority in Evonik, should initiate a merger with LANXESS to create a big specialty chemicals group.
However, in an interview with German business daily Financial Times Deutschland, LANXESS CEO Axel Heitmann rejected the idea.
“To be quite clear: We do not want this, and we do not think this is something that is worth pursuing,” Heitmann said.
Heitmann said LANXESS would drive its growth organically, and possibly through a smaller acquisition of about €1bn ($1.3bn).
LANXESS was reported to be interested in Belgium-based global alkylamines producer Taminco, before private equity firm CVC sold that firm last for €1.1bn to Apollo, another private equity firm. CVC, incidentally, holds a minority stake in Evonik.
($1 = €0.76)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections